# Healthcare Services Group Inc: overview

HCSG · Nasdaq · CIK 731012 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hcsg.md) · [Financials](/companies/hcsg/financials.md) · [Filings](/companies/hcsg/filings.md) · [Insiders](/companies/hcsg/insiders.md)

Latest reported revenue: [$479.6m](/filings/0000731012-26-000059.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 23, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000731012-26-000059).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [438 d](/filings/0000731012-26-000009.md) | [448](/filings/0000731012-26-000031.md) | [458](/filings/0000731012-26-000046.md) | [464](/filings/0000731012-26-000059.md) | [467 d](/filings/0000731012-26-000009.md) | [463](/filings/0000731012-26-000031.md) | [471](/filings/0000731012-26-000046.md) | [480](/filings/0000731012-26-000059.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [2.7% d](/filings/0000731012-26-000009.md) | [3.8%](/filings/0000731012-26-000059.md) | [(7.1%)](/filings/0000731012-26-000059.md) | [9.3%](/filings/0000731012-26-000059.md) | [6.7% d](/filings/0000731012-26-000009.md) | [5.6%](/filings/0000731012-26-000059.md) | [4.8%](/filings/0000731012-26-000059.md) | [5.2%](/filings/0000731012-26-000059.md) |
| Diluted EPS | $ per share | not reported | [0.23](/filings/0000731012-26-000031.md) | [(0.44)](/filings/0000731012-26-000046.md) | [0.59](/filings/0000731012-26-000059.md) | not reported | [0.37](/filings/0000731012-26-000031.md) | [0.32](/filings/0000731012-26-000046.md) | [0.36](/filings/0000731012-26-000059.md) |
| Free cash flow | $m | [34.8 d](/filings/0000731012-26-000009.md) | [25.8](/filings/0000731012-26-000031.md) | [27.4 d](/filings/0000731012-26-000046.md) | [70.0 d](/filings/0000731012-26-000059.md) | [16.0 d](/filings/0000731012-26-000009.md) | [42.3](/filings/0000731012-26-000031.md) | [20.2 d](/filings/0000731012-26-000046.md) | [28.1 d](/filings/0000731012-26-000059.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,642](/filings/0000731012-24-000025.md) | [1,690](/filings/0000731012-25-000032.md) | [1,671](/filings/0000731012-26-000009.md) | [1,716](/filings/0000731012-26-000009.md) | [1,837](/filings/0000731012-26-000009.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [3.0%](/filings/0000731012-24-000025.md) | [2.0%](/filings/0000731012-25-000032.md) | [2.3%](/filings/0000731012-26-000009.md) | [2.3%](/filings/0000731012-26-000009.md) | [3.2%](/filings/0000731012-26-000009.md) |
| Diluted EPS | $ per share | [0.65](/filings/0000731012-24-000025.md) | [0.46](/filings/0000731012-25-000032.md) | [0.52](/filings/0000731012-26-000009.md) | [0.53](/filings/0000731012-26-000009.md) | [0.81](/filings/0000731012-26-000009.md) |
| Free cash flow | $m | [31.4](/filings/0000731012-24-000025.md) | [(13.4)](/filings/0000731012-25-000032.md) | [38.1](/filings/0000731012-26-000009.md) | [24.5](/filings/0000731012-26-000009.md) | [139](/filings/0000731012-26-000009.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/hcsg/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-26 | [Bundick Jason J](/insiders/1594748.md) | EVP/Gen. Counsel/Corp. Secty., Officer | Sale (S) | 18,239 | $25.11 | $458.0k | [Form 4](/filings/0001594748-26-000007.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $279.4m | 11,375,365 |  | Reduced −83,231 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $124.8m | 5,080,313 |  | Added +234,180 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $74.7m | 3,040,374 |  | Reduced −79,171 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $71.6m | 2,916,008 |  | Added +96,883 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $65.4m | 2,661,455 |  | Added +153,028 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $62.9m | 2,562,011 |  | Added +517,415 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $61.0m | 2,484,818 |  | Added +84,137 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $56.4m | 2,296,772 |  | Added +329,978 |
| [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $55.4m | 2,255,190 |  | Added +89,446 |
| [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $55.0m | 2,239,224 |  | Added +95,987 |

## Recent filings

[All 897 filings](/companies/hcsg/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 16:04 ET | [10-Q](/filings/0000731012-26-000059.md) | Quarterly report, period 2026-09-30 | 0000731012-26-000059 |
| 2026-10-21 | 07:01 ET | [8-K](/filings/0000731012-26-000055.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000731012-26-000055 |
| 2026-10-07 | 17:00 ET | [8-K](/filings/0000731012-26-000052.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000731012-26-000052 |
| 2026-07-24 | 16:04 ET | [10-Q](/filings/0000731012-26-000046.md) | Quarterly report, period 2026-06-30 | 0000731012-26-000046 |
| 2026-07-22 | 07:04 ET | [8-K](/filings/0000731012-26-000040.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000731012-26-000040 |
| 2026-05-27 | 16:14 ET | [8-K](/filings/0000731012-26-000036.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000731012-26-000036 |
| 2026-04-24 | 17:20 ET | [10-Q](/filings/0000731012-26-000031.md) | Quarterly report, period 2026-03-31 | 0000731012-26-000031 |
| 2026-04-22 | 07:01 ET | [8-K](/filings/0000731012-26-000025.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000731012-26-000025 |
| 2026-04-15 | 17:04 ET | [DEF 14A](/filings/0000731012-26-000021.md) | Proxy statement, period 2026-05-26 | 0000731012-26-000021 |
| 2026-04-13 | 17:28 ET | [8-K](/filings/0000731012-26-000015.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000731012-26-000015 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000731012-26-000009.md), filed Feb 13, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 731012
- Tickers: HCSG
- Exchange: Nasdaq
- SIC code: 8050 Services-Nursing & Personal Care Facilities
- State of incorporation: PA
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 13:40 ET. No prices; not investment advice.